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When Abraham et al. embarked on the study described in
their 1971 paper,1 it was already known that high adult
body weight is a risk factor for cardiovascular disease
(CVD) and that childhood and adult weight tend to be pos-
itively correlated. They wanted to find out if childhood
weight makes an independent contribution to CVD risk
over and above its correlation with adult weight. They suc-
cessfully re-traced  700 men who attended schools in
Hagerstown, MD, USA, between 1923 and 1928 and had
weight recorded at the age of 9–13 years, and measured
adult weight, CVD risk markers (blood pressure, glucose
and lipids) and four morbidities (‘diabetes’, ‘hypertensive
vascular disease’, ‘arteriosclerotic heart disease’, ‘cardio-
vascular renal disease’). They analysed the data by tabulat-
ing these outcomes across categories of childhood and
adult weight, and then cross-tabulating them according to
both childhood and adult weight simultaneously. This
must have been one of the first studies to investigate the
relationship of an early life characteristic to adult CVD.
They started out with three possible ‘causal pathways’
in mind (Figure 1): (i) childhood weight is positively associ-
ated with adult weight, but most of the variability in CVD
risk is explained by adult weight; (ii) childhood weight is
positively associated with risk, and adult weight has no
independent additional effect; or (iii) both childhood and
adult weight are positively and independently associated
with risk, or in other words a component of higher child-
hood weight that is not encapsulated in adult weight is
associated with increased risk. A fourth possibility (iv) was
that childhood and adult weight are independently associ-
ated with risk but in opposite directions, such that lower
child weight, or a component of it, is associated with
increased risk.
Abraham’s analysis confirmed a strong correlation
between childhood and adult weights. Children in the
highest or lowest weight categories tended to remain in the
same categories as adults. The risk for most of the CVD
outcomes increased with increasing adult body weight.
Though not so strongly, most of the outcomes also
increased with increasing childhood weight. However, in
the cross-tabulations, they found something unexpected.
The highest morbidity appeared to be among those men
who were lightest as children but heaviest as adults.
One problem with their analysis was that, because of
the correlation between childhood and adult weight, the
lightest child-heaviest adult cell in these tables contained
very few men (N< 10). They also tried grouping the men
according to the degree of change in weight category
between childhood and adulthood. Again, small numbers
in key cells substantially defeated them, but they concluded
that the highest morbidity was in men who had the greatest
upward change in body weight. They could not test most
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of these associations statistically with the tests available at
that time, due to small numbers and limited software.
However, they concluded that the overweight adult who
had been a below average weight child had the highest
adult CVD morbidity, and that morbidity was ‘a function
of adult acquired ‘fatness’.’ To paraphrase their conclu-
sions: fat ‘thin’ men, who had been thin children and
became fat adults, were at higher risk than fat ‘fat’ men,
who had been fat all their lives.
How would we tackle this question today? Like
Abraham et al., we might initially do some cross-
tabulations. Despite the problems of low numbers in
extreme cells, this is a good way of getting to know such
data, but is too often left out nowadays in the rush to con-
struct a regression model. A similar method, that adds fur-
ther information, is to create contour plots, which can be
designed in such a way that contours only appear where
there are sufficient data. Figure 2 shows hypothetical con-
tour plots for the scenarios depicted in Figure 1.
We would probably then go on to use multiple regres-
sion, and examine associations between childhood weight
and adult risk unadjusted and then adjusted for adult
weight. These two analyses would answer two separate
questions. The unadjusted model is ‘forward-looking’.
Only childhood weight is known, and we are like a paedia-
trician with a child standing in front of us, trying to predict
its future CVD risk. The association between childhood
weight and the outcome is therefore the total or ‘net’ effect
of childhood weight, including any effect acting through its
positive association with adult weight and any positive
(Figure 1c) or negative (Figure 1d) effect that does not act
through adult weight. The second question is ‘backward-
looking’. We now know adult weight, and are like an adult
physician with the person standing in front of us, trying to
isolate the contribution made by his or her childhood
weight. The effect of childhood weight in a model adjusted
for adult weight will reflect its independent contribution.
It sounds simple, but in reality it is not easy to interpret
the results. We have been grappling with similar problems
over many years, in relation to ‘developmental origins of
adult health and disease’ (DOHaD) concepts, trying to dis-
entangle associations between birthweight, adult body
mass index (BMI) and adult CVD. One issue is that when
there are only two measurements to predict the outcome
(childhood weight and adult weight), it is impossible to
separate the effects of childhood weight, adult weight and
Figure 1. Alternative ‘causal pathways’ linking child and adult weight to CVD morbidity. Heavy black arrows represent main independent effects;
dashed arrows represent correlations, but no/little independent effect on the outcome
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the growth that led from one to the other, which is just the
difference between them; a greater difference could result
from lower early weight or higher later weight, or both. It
also gives no information about the importance of the tim-
ing of weight change. When both childhood weight and
adult weight are included in the model, an inverse associa-
tion between childhood weight and morbidity could mean
that morbidity is associated either with low childhood
weight or with a greater change in weight between child-
hood and adulthood. This was pointed out by Lucas et al.
in relation to the inverse association between birthweight
and adult blood pressure.2 They argued that the inverse
association between birthweight and adult blood pressure
after adjusting for adult BMI indicates that accelerated
post-natal growth, rather than programming by fetal
undernutrition, could be a cause of hypertension. The truth
is that it is impossible to distinguish between these two
possibilities when these are the only data available. This is
conceptually identical to the ‘age, period, cohort’ problem
in epidemiology, where it is known to be impossible to dis-
entangle the effects of year of birth, age at death and year
of death on disease mortality rates.3
A helpful step is to examine whether the association
between adult weight and morbidity differs at different lev-
els of childhood weight. If so, then there is a statistical
interaction, which suggests that childhood weight modifies
the effects of adult weight. An example, using risk con-
tours, is shown using data from the 1923–33 Helsinki birth
cohort study from Finland (Figure 3). In this example, the
earlier measure is ponderal index at birth, and the later
measure is BMI at age 11 years. A higher 11-year BMI is
associated with an increased risk of adult coronary heart
disease in adult life, but the increase in risk is greater
among men who were thin (had a low ponderal index) at
birth than among men who had a high ponderal index at
birth. This gives more confidence that thinness at birth is
intrinsically important in relation to later CVD.
Abraham et al. would have benefited from having data
at intervening time points between childhood and adult
life. Statistical methods have been developed to use serial
Figure 2. Hypothetical contour plots corresponding to the ‘causal pathways’ shown in Figure 1. Increasing thickness of the contour lines represents
increasing risk
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childhood measurements to isolate associations of size and
growth at specific ages with later outcomes. For example,
conditional variables are standardized residuals derived
from regressing size (e.g. weight) at any age on previous
size measurements, producing independent, uncorrelated
variables representing greater or lesser size at each age
than expected, given earlier size.5,6 They overcome the
problems caused by the strong correlations between serial
measures of body size in an individual.
The conditional method can be used to take both
‘forward-looking’ and ‘backward-looking’ approaches.
Figure 4 shows data from the 1934–44 Helsinki birth
cohort study, in which birthweight, weight at 2 years and
BMI at 11 years were available. Adult BMI was based on
actual measurements, and hypertension was defined by use
of medications.7 In the forward-looking analysis, without
adult weight (Figure 4a), lower birthweight and higher
conditional BMI at age 11 years were associated with an
increased risk of adult hypertension. The data could also
be interpreted as showing that lower birthweight and
greater weight gain between 2 and 11 years were associ-
ated with adult hypertension. Conditional weight at 2
years (or weight gain between birth and 2 years) was unre-
lated to hypertension. These are the ‘net effects’ of early
size.
Now, if adult BMI is included in the model (Figure 4b)
we get the ‘backward-looking view. Knowing adult BMI,
conditional BMI at 11 years is no longer positively related
to hypertension. This suggests that the positive association
of conditional 11-year BMI in the forward-looking analysis
was acting on adult hypertension risk mainly through adult
BMI. The associations of 2-year conditional weight and
11-year conditional BMI with hypertension have both
become, like that of birthweight, negative or inverse. We
conclude that a component of 11-year BMI tracks through
into adult BMI and is a risk factor for adult hypertension.
But there is also a component of weight at 11 years, 2 years
and birth whereby a lower body weight is an independent
risk factor for later hypertension. These conclusions are
substantially similar to those reached by Abraham, but
give more information about weight at different ages in
Figure 4. Birthweight and conditional measures of childhood weight and BMI as predictors of adult hypertension in the 1934–44 Helsinki birth cohort;
y, years
Figure 3. Hazard ratios for death from coronary heart disease for men
born in Helsinki 1924–33 according to ponderal index at birth and BMI
at age 11 years. Arrows indicate average values.
Source: Eriksson et al. 19994
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childhood. The conditional growth approach has been
extended to include not only multiple ages, but also multi-
ple measures of body size. For example, Adair et al. have
investigated independent effects of childhood soft tissue
and linear growth on adult human capital and CVD risk
markers;6 And Krishnaveni et al. have investigated inde-
pendent effects of earlier growth in height, adiposity and
lean body mass on CVD risk markers in adolescence.8 The
latter study suggested that the positive net effect of child-
hood weight gain on later blood pressure was mediated by
growth in adiposity, and not by linear or lean-tissue
growth. Other modelling approaches, in addition to the
conditional approach, have been recently reviewed.9
Apart from the above considerations, a full interpreta-
tion of epidemiological data like that of Abraham et al.
would also require evaluation of confounding (the possibil-
ity that both childhood weight and CVD outcomes are cau-
sally related to some other factor, such as: low
socioeconomic status); selection bias (the possibility that
the association between childhood weight and CVD dif-
fered between people who were included in the analysis
and those who were not); and the influence of missing data
and measurement error. In relation to selection bias,
Abraham et al. compared childhood weights between those
who were and were not re-traced/studied, but could not
have answered the more critical question as to whether the
association between childhood weight and outcomes dif-
fered between these two groups.
Abraham et al., in their discussion, speculated about the
biology (‘different types of fat’) underlying their results. It
is worth bringing to bear on this the greater understanding
of the biology linking factors in early life to adult disease,
that has come from recent research. In the DOHaD world,
nobody believes that weight per se (birthweight or child-
hood weight) ‘causes’ anything. As Gillman wrote in rela-
tion to birthweight, weight is not a ‘monolith’;10 weight is
made up of multiple components (muscle, bone, fat, differ-
ent organs and tissues) whose development is influenced by
multiple environmental factors. It is the effects of these fac-
tors on individual developing tissues, and the end result in
terms of their structure and function across the life course,
which are thought to cause later disease.
Another effect of the same environmental influences
may be, though not invariably, to alter body weight.
Hence we can start to see a scenario whereby some mecha-
nisms linking early life weight to adult CVD may differ
from the mechanisms linking early life weight to adult
weight. One component of early life weight may reflect an
exposure that causes an individual to develop later CVD,
whereas another may reflect the tracking of weight into
adult life, influencing CVD risk in a different way. To flesh
this out with an example, adult blood pressure could be
high because an individual has reduced numbers of neph-
rons in the kidneys, resulting from a specific nutritional
deficiency in the mother when the fetal kidney was devel-
oping.11 This could also reduce birthweight. However,
fetal adiposity may be unaffected by this maternal defi-
ciency, and the newborn has a normal quantity of body
fat. The usual relationship between newborn adiposity and
adult adiposity pertains, and partly determines adult
adiposity and body weight, which are positively associated
with blood pressure. One component of birthweight (kid-
ney weight) would be negatively associated with adult
blood pressure, but another (body fat) would be positively
associated with blood pressure. The persuasive evidence
that early life factors are important in the causation of
adult CVD rests not so much on the associations with early
life body weight as on new observations that these associa-
tions stimulated. Animal experiments have shown that
adult blood pressure, insulin sensitivity, glucose tolerance
and body composition can be influenced by manipulating
the mother’s diet during pregnancy, and that these effects
are matched by changes in individual tissues and metabolic
pathways.12 We are far from understanding early life
effects at this level in humans, and Abraham et al. were
even further from that but their speculations, about
‘acquired’ fat being different from ‘endogenous’ fat, high-
light the need to delineate underlying mechanisms in order
to make sense of the body weight associations.
The article by Abraham et al. reminds us how far we
have come in terms of the ‘tools’ of life course epidemiol-
ogy. They had to trace their study subjects manually from
the school records, using telephone directories, service lists
and death certificates. They traced an impressive 717 out
of 1963 schoolchildren, but paid a price in laboriousness
and missing data. The morbidities they studied were not
defined, and some of them are all but unrecognizable
now. We benefit today from computerized records, growth
standards, standardized disease definitions and a far more
sophisticated statistical armamentarium. These
advances have revolutionized what we can learn from
data, but cannot deal with all the limitations of the data
themselves.
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I began my formal introduction to cardiovascular epidemi-
ology when I enrolled in the University of North Carolina
Chapel Hill-School of Public Health; my informal intro-
duction began when I was 6 years old. My father, David
Kritchevsky, was a biochemist and expert in animal models
of atherosclerosis. Growing up, our dinner table conversa-
tion routinely included discussions about studies like the
Ni-Hon-San study1 and the Irish-Brothers Study.2 Being an
e´migre´ himself, my father was interested in the immigrant
health experience. The pattern seen for cardiovascular and
many other diseases was that disease rates approached
those of the destination country with the length of time in
the new country, indicating that acculturation and early
life experiences shape adult chronic disease risk.
The ‘Relationship of childhood weight status to mor-
bidity in adults’3 buttresses the concept that early life expe-
rience shapes cardiovascular risk. The authors report on
717 men (mean age 48 years) from Hagerstown,
Maryland, examined between 1961 and 1963 and who
had height and weight information in their elementary
school records from between 1923 and 1928 when they
were 9–13 years old. In this sample, being ‘markedly over-
weight’ as an adult–defined by measured weight relative to
‘ideal weight’–was associated with blood glucose, beta-
lipoprotein levels (a precursor to LDL cholesterol determi-
nations) and blood pressure. For the most part, childhood
weight status was not associated with adult risk factor sta-
tus, with one notable exception. Risk factor levels were
most adverse in those who were underweight as children
but more than 20% heavier than ideal weight as adults.
This observation is summoning. What is it about being
underweight when young that makes lifelong weight gain
deleterious? Would it have made a difference if the weight
status was assessed at 5 years of age or at 1 year or at
birth? Is this generalizable to women? On the other end of
the life-span, would it make a difference if weight was
assessed at 60 years or 80 years? Does this phenomenon
obtain to more than just cardiovascular disease risk?
Data relevant to many of these questions have appeared
since the publication of ‘Relationship of childhood weight
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